PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12118482

Considering changes to CMS's national coverage decision process: applying lessons learned from FDA as a regulator of access to healthcare technology.

Christopher D Zalesky
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Biomedical TechnologyCenters for Medicare and Medicaid Services, U.S.Decision MakingHealth Services AccessibilityHumansInsurance CoverageInsurance, Pharmaceutical ServicesMedicareOrganizational CultureUnited StatesUnited States Food and Drug AdministrationJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Christopher D Zalesky. 2002. Considering changes to CMS's national coverage decision process: applying lessons learned from FDA as a regulator of access to healthcare technology.. https://pubmed.ncbi.nlm.nih.gov/12118482/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Cost of cancer care: issues and implications.

Medical technology is increasingly costly in most fields of clinical medicine. Oncology has not been spared from issues related to cost, in part resulting from the tremendous scientific progress that has lead to new tools for diagnosis, treatment, and follow-up of our patients. The increasing cost of health care in general (and cancer care in particular) raises complex questions related to its effects on our economy and the citizens of our society. This article reviews the macroeconomic principles and individual behaviors that govern medical spending, and examines how cost disproportionately affects various populations. Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology.

Biomedical Technology↗